Due to exacerbated inflammation, anti–TNF-α biologics are approved for autoimmune diseases such as rheumatoid arthritis, psoriasis, Crohn’s disease, and ulcerative colitis (74). The gene discussed is TNF; the disease is autoimmune disease.